NCT05643768

Brief Summary

This clinical research study will investigate the effects of 6 weeks of inspiratory muscle strength training on metabolic and cardiovascular outcomes in adults with recent-onset type 2 diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 9, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

June 30, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 6, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 6, 2024

Completed
Last Updated

June 14, 2024

Status Verified

June 1, 2024

Enrollment Period

10 months

First QC Date

November 30, 2022

Last Update Submit

June 13, 2024

Conditions

Keywords

insulin sensitivityblood pressureblood glucosenon-pharmacologicalinspiratory resistance training

Outcome Measures

Primary Outcomes (3)

  • Change from baseline fasting blood plasma glucose after 6 weeks of IMST

    A blood sample will be collected after 12 hours of fasting. Blood and plasma will be separated and plasma glucose levels will be quantified.

    Blood plasma collected and analyzed at baseline and after 6 weeks of training

  • Change from baseline fasting blood plasma Insulin after 6 weeks of IMST

    A blood sample will be collected after 12 hours of fasting. Blood and plasma will be separated and plasma insulin levels will be quantified.

    Blood plasma collected and analyzed at baseline and after 6 weeks of training

  • Change from baseline insulin sensitivity after 6 weeks of IMST

    A blood sample will be collected after 12 hours of fasting. Insulin sensitivity will be calculated using the homeostatic model assessment of insulin resistance (HOMA-IR): (fasting serum insulin (mU/L) × fasting plasma glucose (mmol/L) × 22.5).

    Blood plasma collected and analyzed at baseline and after 6 weeks of training

Secondary Outcomes (2)

  • Change from baseline systolic blood pressure after 6 weeks of IMST

    Blood pressure will be assessed at baseline and after 6 weeks of training

  • Change from baseline Nitric Oxide-mediated Endothelial Dependent Dilation (EDD)

    EDD will be assessed at baseline and after 6 weeks of training

Other Outcomes (1)

  • Change from baseline proteomic analysis

    Proteomics will be performed at baseline and after 6 weeks of training

Study Arms (2)

High-resistance IMST

EXPERIMENTAL

30 breaths/day (5 sets of 6 breaths, one minute of rest between sets), 5 days/week, 6 weeks

Behavioral: Inspiratory muscle strength training (IMST)

Low-resistance IMST

ACTIVE COMPARATOR

30 breaths/day (5 sets of 6 breaths, one minute of rest between sets), 5 days/week, 6 weeks

Behavioral: Inspiratory muscle strength training (IMST)

Interventions

30 breaths/day, 5 days/week, 6 weeks

Also known as: inspiratory resistance training, vascular conditioning exercise, inspiratory muscle training
High-resistance IMSTLow-resistance IMST

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosed with type 2 diabetes by physician
  • fasting plasma glucose levels ≥126 mg/dl and ≤240 mg/dl
  • systolic blood pressure between 120-169 mmHg
  • stable dose of medication (three months on the same dose)
  • weight stable in the prior 3 months (\<3.0 kg weight change) and willing to remain weight stable throughout the study
  • absence of unstable clinical disease as determined by medical history

You may not qualify if:

  • current smoker (including tobacco products, vaping devices, THC, etc…)
  • have an uncontrolled medical condition (e.g., cancer)
  • myocardial infarction or stroke within the previous 12 months
  • performs regular aerobic exercise (\>4 bouts/week)
  • BMI ≥ 40 kg/m2
  • systolic blood pressure \<120 or ≥170 mmHg
  • diastolic blood pressure \>100 or \<60 mmHg
  • Cheyne-Stokes respiration
  • history of perforated eardrum
  • history of glaucoma or retinopathy
  • history of collapsed lung
  • diagnosed with asthma
  • pregnant, breastfeeding, or trying to become pregnant (self-reported)
  • medications that, in the opinion of the study physician or nurse practitioner, may impact the outcomes of the study (e.g., steroids)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arizona Respiratory and Neurophysiology Laboratory

Tucson, Arizona, 85724, United States

Location

Related Publications (1)

  • Craighead DH, Tavoian D, Freeberg KA, Mazzone JL, Vranish JR, DeLucia CM, Seals DR, Bailey EF. A multi-trial, retrospective analysis of the antihypertensive effects of high-resistance, low-volume inspiratory muscle strength training. J Appl Physiol (1985). 2022 Oct 1;133(4):1001-1010. doi: 10.1152/japplphysiol.00425.2022. Epub 2022 Sep 15.

    PMID: 36107991BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 2HypertensionInsulin Resistance

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesVascular DiseasesCardiovascular DiseasesHyperinsulinism

Study Officials

  • Dallin Tavoian, PhD

    University of Arizona

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
This is a randomized trial and participants will be blinded to their allocation group.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Participants will be randomly allocated using a 1:1 ratio to A) High-Intensity Training Group (75 % maximal inspiratory pressure) or B)Low-Intensity Training Group (15% maximal inspiratory pressure)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 30, 2022

First Posted

December 9, 2022

Study Start

June 30, 2023

Primary Completion

May 6, 2024

Study Completion

May 6, 2024

Last Updated

June 14, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

There is no plan to make IPD available

Locations